Physician profile
John C Steck
NPI 1366488462
$111,427.84
in general payments reported to CMS, 2019-2025
35 companies · $763 in 2025
The $763 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46K · 2020: $27K · 2021: $19K · 2022: $7,132 · 2023: $11K · 2024: $1,024 · 2025: $763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,350 · Royalty Or License: $2,150 · Food and Beverage: $1,233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,350.00 |
| Royalty Or License | $2,150.37 |
| Food and Beverage | $1,233.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Precision Spine, INC. | $86,724.86 | 2019-2022 | |
| Medyssey USA, INC | $11,450.00 | 2022-2023 | |
| Globus Medical, INC. | $5,554.85 | 2019-2025 | Ellipse/Addition C, Ellipse, Excelsius3d Imaging System |
| Alphatec Spine, INC | $2,365.81 | 2020-2021 | |
| Nuvasive, INC. | $2,340.34 | 2019 | |
| The Institute of Musculoskeletal Science and Education | $1,083.43 | 2019-2020 | |
| Corelink, LLC | $217.83 | 2022 | |
| Wenzel Spine, INC. | $170.63 | 2023 | Varilift |
| Orthofix Medical, INC. | $164.72 | 2023 | Trinity Elite |
| Stryker Corporation | $148.50 | 2019 | |
| 4web, INC. | $146.72 | 2023 | Spine Truss System |
| Integrity Implants INC. Dba Accelus | $123.08 | 2024 | |
| Carlsmed, INC. | $120.41 | 2022 | |
| Zimmer Biomet Holdings, INC. | $117.75 | 2024 | Neuro Plating System |
| Longeviti Neuro Solutions INC | $116.47 | 2023 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $112.50 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Amgen INC. | $57.18 | 2021-2022 | |
| Nevro Corp. | $50.74 | 2019 | |
| Medtronic, INC. | $50.45 | 2021-2025 | Kyphon Express II Kyphopak Tray |
| Biogen, INC. | $32.93 | 2024 | Skyclarys, Vumerity, Tysabri |
| Abbott Laboratories | $30.80 | 2022 | |
| Neurocrine Biosciences, INC. | $25.56 | 2024 | Ingrezza |
| Merz Pharmaceuticals, LLC | $23.95 | 2023 | Xeomin |
| Si-Bone, INC. | $20.84 | 2024 | |
| Innovation Technologies INC | $18.43 | 2024 | Irrisept |
| Eisai INC. | $18.41 | 2021 | |
| Organogenesis INC. | $18.30 | 2023 | Puraply |
| Silk Road Medical, INC. | $18.14 | 2022 | |
| Saluda Medical Americas, INC. | $17.84 | 2025 | Evoke |
| Abbvie INC. | $16.58 | 2025 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $15.81 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $14.70 | 2021 | |
| Assertio Therapeutics, INC. | $14.29 | 2019 | |
| Lilly USA, LLC | $13.15 | 2024 | Amyvid |
| Medtronic USA, INC. | $11.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Steck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.